CureVac to Participate in Upcoming Investor Conferences
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced that it will be participating in the following upcoming investor conferences:
- Leerink 10th Annual Global Healthcare Conference (virtual)
Wednesday, February 24, 2021
Presentation: 8:00 am EST - Credit Suisse 2021 London Global Healthcare Conference (virtual)
Tuesday, March 2, 2021
Fireside Chat: 12:00 pm GMT / 7:00 am EST